These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28578671)

  • 1. Serious child and adolescent behaviour disorders; a valuation study by professionals, youth and parents.
    Vermeulen KM; Jansen DEMC; Buskens E; Knorth EJ; Reijneveld SA
    BMC Psychiatry; 2017 Jun; 17(1):208. PubMed ID: 28578671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrafamilial disruptive behaviour disorders in children and adolescents: Present data and treatment prospects].
    Bousquet E; Franc N; Ha C; Purper-Ouakil D
    Encephale; 2018 Apr; 44(2):176-182. PubMed ID: 29153459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity of disruptive behavioral disorders and attention-deficit hyperactivity disorder--indicator of severity in problematic behavior?
    Nordström T; Ebeling H; Hurtig T; Rodriguez A; Savolainen J; Moilanen I; Taanila A
    Nord J Psychiatry; 2013 Aug; 67(4):240-8. PubMed ID: 23126481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcissism and Callous-Unemotional Traits Prospectively Predict Child Conduct Problems.
    Jezior KL; McKenzie ME; Lee SS
    J Clin Child Adolesc Psychol; 2016; 45(5):579-590. PubMed ID: 25651338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome.
    Ghanizadeh A; Mosallaei S
    Brain Dev; 2009 Jan; 31(1):15-9. PubMed ID: 18558469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between behavioral symptoms of non-medicated Chinese children with attention deficit hyperactivity disorder and parenting stress: Comparison of different subtypes and comorbidities.
    Li Y; Jiang WQ; Du YS; Coghill D
    Asia Pac Psychiatry; 2016 Jun; 8(2):127-35. PubMed ID: 26403485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation study on behavioral problems and self-concept of children with oppositional defiant disorder.
    Chen L; Luo X; Wei Z; Guan B; Yuan X; Ning Z; Ding J; Yang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):217-22. PubMed ID: 21464542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG; Sener S
    Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting effects of the indicated prevention Programme for Externalizing Problem behaviour (PEP) on child symptoms, parenting, and parental quality of life in a randomized controlled trial.
    Hanisch C; Freund-Braier I; Hautmann C; Jänen N; Plück J; Brix G; Eichelberger I; Döpfner M
    Behav Cogn Psychother; 2010 Jan; 38(1):95-112. PubMed ID: 19995467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates.
    Freeman AJ; Youngstrom EA; Youngstrom JK; Findling RL
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):123-30. PubMed ID: 26745325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.
    Gorman DA; Gardner DM; Murphy AL; Feldman M; Bélanger SA; Steele MM; Boylan K; Cochrane-Brink K; Goldade R; Soper PR; Ustina J; Pringsheim T
    Can J Psychiatry; 2015 Feb; 60(2):62-76. PubMed ID: 25886657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satisfaction of parents with their conduct-disordered and substance-abusing youth.
    Donohue B; DeCato LA; Azrin NH; Teichner GA
    Behav Modif; 2001 Jan; 25(1):21-43. PubMed ID: 11151483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Symptomatology and psychosocial adaptation in adolescents with depressive disorder and comorbid disruptive behaviour disorder].
    Toupin J; Le Corff Y; Pauzé R
    Can J Psychiatry; 2008 Jan; 53(1):43-51. PubMed ID: 18286871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common Questions About Oppositional Defiant Disorder.
    Riley M; Ahmed S; Locke A
    Am Fam Physician; 2016 Apr; 93(7):586-91. PubMed ID: 27035043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.